Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 18 11:45AM ET
14.89
Dollar change
+0.05
Percentage change
0.36
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-8.04% Shs Outstand Perf Week1.98%
SponsorWisdom Tree ETF Type Tagsequity Return% 3Y-9.99% Total Holdings90 Perf Month3.09%
Fund Family Bond Type Tagsbiotechnology Return% 5Y- AUM2.23M Perf Quarter-6.37%
IndexWisdomTree BioRevolution Index Average Maturity Tags- Return% 10Y NAV% Perf Half Y-7.24%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-7.71%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range14.31 - 17.96 Perf YTD3.65%
Dividend TTM0.11 (0.72%) ESG Type Tags- Flows% 3M0.00% 52W High-17.09% Beta1.07
Dividend Ex-DateDec 26, 2024 Dividend Type Sector/Theme Flows% YTD0.00% 52W Low4.09% ATR (14)0.20
Expense0.45% Structure Type Region Flows% 1Y RSI (14)50.78 Volatility0.98% 0.70%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume4.49 Prev Close14.84
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume0.96K Price14.89
SMA20-0.30% SMA50-0.19% SMA200-6.11% Trades Volume1,630 Change0.36%
WisdomTree BioRevolution Fund seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index ("index"). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.